Oral treprostinil: Completed Phase III enrollment

United Therapeutics completed enrollment of 349 PAH patients in the 12-week,

Read the full 117 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE